CD4 and urinary bladder carcinoma: For instance, in a cohort of 244 patients with metastatic bladder cancer, intratumoral cytotoxic CD4 T cells with distinct expression of proliferation markers have been identified and correlated with clinical response to anti-programmed death ligand-1 therapy,32–34 thus overcoming a mere helper role previously conceived for CD4 T cells.